“…Targeted nanoparticles should be carefully designed in terms of size, structure, composition, and functionalization to balance their stability, diffusion, specificity, and biocompatibility. Currently, there are several nanosystems based on liposomes-, polymeric-, micellar-, metallic-, or protein-based nanoparticles that are approved by the Food and Drug Administration (FDA) for medical applications [ 4 , 19 , 20 , 21 , 22 , 23 , 24 , 28 , 29 , 30 ]. Among them, silica nanoparticles (SN), have been receiving special attention due to their wide spectrum of applications.…”